Monoclonal Antibody Diagnostic Reagent Market Forecast to 2028 – COVID

Monoclonal Antibody Diagnostic Reagent Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Tests (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Recombinant Immunoblot Assay, and Dot-immunogold Filtration Assay) and Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis, and Others)

Report Code : TIPRE00027682 | Region : Global | Industry : Medical Device | Published Date : 30/Sep/2022

The monoclonal antibody diagnostic reagent market is expected to grow from US$ 7,654.06 million in 2021 to US$ 18,507.20 million by 2028; it is expected to grow with a CAGR of 13.5% from 2022 to 2028.

The rising prevalence of cancer & other chronic diseases, extensive R&D efforts to develop novel therapies, and the presence of a strong pipeline of drugs under trial are the major factors boosting the market growth.

As per the American Cancer Society report, the population of cancer survivors in the US is expected to grow from ~16.9 million (since January 2019) to 22.1 million by January 2030 due to the rising aging population. Therefore, the demand for biologics such as monoclonal antibodies (mAbs) is high owing to the rising prevalence of cancer and other chronic diseases. Biologics play a key role in cancer treatment due to the presence of its principal components in many therapeutic regimens and the cost-effectiveness of treatment for patients.

Most licensed mAbs effectively treat noncommunicable diseases, including cancers and autoimmune diseases. Furthermore, successful immunotherapies involving more than 40 licensed mAbs are efficient for revolutionizing cancer treatment and have significantly improved patients' overall and long-term survival compared to traditional approaches such as chemotherapy.

According to the International AIDS Vaccine Initiative (IAVI) report, the development of mAbs is one of the fastest-growing segments of biomedical research. Further, more than 50 mAbs were licensed in the last six years, and in 2019, seven of the ten best-selling novel drugs for cancer and autoimmune diseases were mAbs. Further, the demand for mAbs has increased with the growing number of noncommunicable and infectious diseases for which mAbs are or might prove effective treatment. The sale of mAbs is predominant in the US, Canada, and Europe. Also, in terms of availability of mAbs in middle-income countries, India represents one of the most ideal countries, largely due to extensive biosimilar manufacturing capacity.

Moreover, several countries are taking strong initiatives to shorten the regulatory process for mAbs that are effective in the treatment of chronic diseases. For example, the Chinese Food and Drug Administration (CFDA), in 2017, announced a collaboration with the International Council for Harmonization to align regulatory processes relating to international standards, resulting in the approval of a number of mAbs, annually. In early 2019, the CFDA approved three mAbs from domestic developers and ten mAbs from multinational pharmaceutical companies. Such factors are stimulating the uptake of mAbs, which is contributing to the monoclonal antibody diagnostic reagent market growth.

Tests Insights

Based on tests, the monoclonal antibody diagnostic reagent market is segmented into double antigen sandwich chemiluminescence method, enzyme linked immunosorbent, assay recombinant immunoblot assay, and dot-immunogold filtration assay. The enzyme-linked immunosorbent assay segment is likely to hold the largest market share in 2022, and it is anticipated to register the highest CAGR during the forecast period. The rise in the number of chronic diseases increases the demand for the enzyme-linked immunosorbent assay (ELISA) tests for the diagnosis of hepatitis, AIDs, influenza, herpes simplex, chlamydia infections, and cancer, which is driving the growth of the enzyme-linked immunosorbent assay segment.

Application-Based Insights

Based on application, the monoclonal antibody diagnostic reagent market is segmented into hormones diagnosis, tumor monitoring, virus detection, and others. The tumor monitoring segment is likely to hold the largest market share in 2022, and it is expected to register the highest CAGR from 2022 to 2028. Monoclonal antibody diagnostic reagents are widely used in the field of cancer diagnostics. The use of antibodies linked with fluorescent dyes or enzymes enables the detection of cancer and also determines the type of cancer. All these factors are driving the growth of the tumor monitoring segment.

The National Center for Biotechnology Information (NCBI), Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Food and Drug Administration (FDA), American Society of Clinical Oncology (ASCO), Canadian Cancer Statistics, GTAI (Germany Trade and Invest), Health Ministry of Spain, Business Monitor International, National Institute of Population and Social Security Research Japan, Department of Health-Abu Dhabi, Globocan, Department of Emergency Medicine, and International AIDS Vaccine Initiative (IAVI) report are among the primary and secondary sources referred to while preparing the report on the monoclonal antibody diagnostic reagent market.

Rising Prevalence of Cancer and Other Chronic Diseases to Drive Global Monoclonal Antibody Diagnostic Reagent Market

According to our new market research study, titled "Monoclonal Antibody Diagnostic Reagent Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Tests and Application," the market is expected to grow from US$ 7,654.06 million in 2021 to US$ 18,507.20 million by 2028, it is estimated to grow at a CAGR of 13.5% from 2022 to 2028. The report highlights trends prevailing in the market and drivers and restraints pertaining to the global monoclonal antibody diagnostic reagent market growth.

Monoclonal antibodies (mAb) are important diagnostic reagents that are being used in biomedical research; microbiological research; in the diagnosis of Hepatitis, AIDs, influenza, herpes simplex, chlamydia infections; and in the treatment of infections and cancer. The monoclonal antibodies being directed at single epitopes are highly specific, homogeneous, and can be produced in unlimited quantities. The hybridoma-derived or bacterially cloned monoclonal antibody technology has enabled the mass production of highly specific probes for antigenic sites, whether on hormones, enzymes, receptors, or microbial products.

According to the NCBI report, researchers have identified therapeutic applications for mAbs since their development. mAbs possess many promising potential therapeutic applications, such as treating asthma, autoimmune diseases, cancer, poisoning, septicemia, substance abuse, viral infections, and other diseases. Additionally, in therapeutic applications, mAbs can be utilized in their naked form or as carriers by being conjugated to a tiny molecule or drug. Moreover, monoclonal antibody-based technology acts as an important tool in discovering novel therapeutic targeted drugs and developing novel therapeutic agents such as antibody-based drugs.

In 2020, North America holds the largest share in the monoclonal antibody diagnostic reagent market, whereas Asia Pacific is expected to register the highest CAGR during the forecast period. Regulatory approvals for innovative mAb products will positively influence the monoclonal antibody diagnostics reagent market revenue. Growing usage of innovative genetic technologies will offer faster discovery and product development. Moreover, wide-ranging R&D activities by numerous organizations support new product launches in the region. Further, the high occurrence of chronic diseases, including cancer and infections, across the region is creating the need for product innovation, which is driving the monoclonal antibody diagnostic reagent market in North America. Further, the US monoclonal antibody diagnostic reagent market is expected to grow from US$ 3,194.65 million in 2021 to US$ 7,917.45 million by 2028 at a CAGR of 13.9% during the forecast period. Monoclonal antibody-based cancer treatment has been recognized as one of the most successful therapeutic strategies for hematologic and solid tumors. According to National Cancer Institute (NCI) An estimated 1,806,590 new cases of cancer were detected in the US, and ~606,520 associated deaths were registered in 2020. Such factors are responsible for boosting the expansion of biologics such as monoclonal antibodies, which is driving the market growth.

According to The College of Physicians of Philadelphia report, the US Congress passed the Biologics Control Act to regulate the sale of viruses, serums, toxins, and analogous products. Due to this act the laboratories of the US Health Public Service has started overlooking the manufacturing of biologics. Moreover, the Food and Drug Administration (FDA) supported the development of monoclonal antibodies during the rising number of COVID-19 cases. For instance, in December 2021, the FDA announced expanding the emergency use authorization (EUA) of "bamlanivimab" and "etesevimab" effective for treating mild to moderate symptoms of COVID-19 in all younger pediatric patients, including newborns.

During the initial phase of the COVID-19 pandemic, there was a rapid growth of COVID-19 cases, which led to the high demand for the diagnosis of COVID-19 among the population. For instance, the European Commission signed a contract with Eli Lilly, a pharmaceutical company, to supply a monoclonal antibody treatment for COVID-19-infected patients. It marks the latest development in this first portfolio of five promising therapeutics announced by the European Commission under the EU COVID-19 Therapeutics Strategy in June 2021. The monoclonal antibody diagnostic reagent played a vital role in the diagnosis of COVID-19 patients, which increased the product demand.

BioGenex; Bio-Rad Laboratories, Inc.; Biocare Medical, LLC; Celltrion Healthcare Co., Ltd.; Creative Diagnostics; GenWay Biotech; Thermo Fisher Scientific Inc.; ABclonal, Inc.; Apto-Gen; and Abcam plc are a few of the leading companies operating in the global monoclonal antibody diagnostic reagent market.

By geography, the monoclonal antibody diagnostic reagent market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South and Central America).

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialists in industries such as healthcare, media, and telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused on market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, type, end-users, etc., which helps our clients to gain a deeper analytical understanding of various research topics.

Contact Us

If you have any queries about this report or would like further information, please contact us:

 North America: +1 646 491 9876

 Asia Pacific: +91 20 6727 8686

 Email: [email protected]

Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher, "The Insight Partners."

The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the findings, conclusions, and recommendations that "The Insight Partners" delivers will be based on information gathered in good faith from primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such, "The Insight Partners" can accept no liability whatsoever for actions taken based on any information that may subsequently prove to be incorrect.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Monoclonal Antibody Diagnostic Reagent Market – By Tests

1.3.2 Global Monoclonal Antibody Diagnostic Reagent Market – By Application

1.3.3 Global Monoclonal Antibody Diagnostic Reagent Market – By Geography

2. Monoclonal Antibody Diagnostic Reagent Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Monoclonal Antibody Diagnostic Reagent Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South & Central America – PEST Analysis

4.3 Expert Opinion

5. Monoclonal Antibody Diagnostic Reagent Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Cancer and Other Chronic Diseases

5.1.2 Extensive R&D Efforts to Develop Novel Therapies

5.1.3 Presence of Strong Pipeline of Drugs Under Trial

5.2 Market Restraints

5.2.1 Low Awareness, Accessibility, and High Cost

5.3 Market Opportunities

5.3.1 Cost-effective Advanced Technology for Developing mAbs Presents Billion-Dollar Opportunity

5.4 Future Trends

5.4.1 Strategic Research Collaborations

5.5 Impact Analysis

6. Monoclonal Antibody Diagnostic Reagent Market – Global Analysis

6.1 Global Monoclonal Antibody Diagnostic Reagent Market - Revenue Forecast and Analysis

6.1.1 Global Monoclonal Antibody Diagnostic Reagent Market, By Geography - Forecast and Analysis

6.1.2 Global Monoclonal Antibody Diagnostic Reagent Market – Market Potential Analysis, By Region

6.2 Company Analysis

6.2.1 Market Positioning of Key Players

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance of Key Players

6.2.4.1 Thermo Fisher Scientific Inc.

6.2.4.2 Bio-Rad Laboratories, Inc.

7. Global Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028 – by Tests

7.1 Overview

7.2 Global Monoclonal Antibody Diagnostic Reagent Market, By Tests, 2021 & 2028 (%)

7.3 Double Antigen Sandwich Chemiluminescence Method

7.3.1 Overview

7.3.2 Double Antigen Sandwich Chemiluminescence Method: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Enzyme Linked Immunosorbent Assay (ELISA)

7.4.1 Overview

7.4.2 Enzyme Linked Immunosorbent Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Recombinant Immunoblot Assay (RIBA)

7.5.1 Overview

7.5.2 Recombinant Immunoblot Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Dot-immunogold Filtration Assay

7.6.1 Overview

7.6.2 Dot-immunogold Filtration Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

8. Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 Global Monoclonal Antibody Diagnostic Reagent Market Share by Application Segment - 2021 & 2028 (%)

8.3 Hormones Diagnosis

8.3.1 Overview

8.3.2 Hormones Diagnosis: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

8.4 Tumor Monitoring

8.4.1 Overview

8.4.2 Tumor Monitoring: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

8.5 Virus Detection

8.5.1 Overview

8.5.2 Virus Detection: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

8.6 Other Applications

8.6.1 Overview

8.6.2 Other Applications: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9. Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 – Geographical Analysis

9.1 North America: Monoclonal Antibody Diagnostic Reagent Market

9.1.1 Overview

9.1.2 North America: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3 North America: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.1.4 North America: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.1.5 North America: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)

9.1.5.1 US: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1 Overview

9.1.5.1.2 US: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3 US: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.1.5.1.4 US: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.1.5.2 Canada: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1 Overview

9.1.5.2.2 Canada: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3 Canada: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.1.5.2.4 Canada: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.1.5.3 Mexico: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1 Overview

9.1.5.3.2 Mexico: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3 Mexico: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.1.5.3.4 Mexico: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.2 Europe: Monoclonal Antibody Diagnostic Reagent Market

9.2.1 Overview

9.2.2 Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.3 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

9.2.4 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.2.5 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)

9.2.5.1 UK: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.1 Overview

9.2.5.1.2 UK: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.3 UK: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.4 UK: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2 Germany: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.1 Overview

9.2.5.2.2 Germany: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.3 Germany: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.4 Germany: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3 France: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.1 Overview

9.2.5.3.2 France: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.3 France: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.4 France: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4 Italy: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.1 Overview

9.2.5.4.2 Italy: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.3 Italy: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.4 Italy: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5 Spain: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.1 Overview

9.2.5.5.2 Spain: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.3 Spain: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.4 Spain: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.1 Overview

9.2.5.6.2 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.3 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.4 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.3 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market

9.3.1 Overview

9.3.2 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)

9.3.3 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.3.4 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.3.5 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)

9.3.5.1 China: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.1.1 Overview

9.3.5.1.2 China: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.1.3 China: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.3.5.1.4 China: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.3.5.2 Japan: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.2.1 Overview

9.3.5.2.2 Japan: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.2.3 Japan: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.3.5.2.4 Japan: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.3.5.3 India: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.3.1 Overview

9.3.5.3.2 India: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.3.3 India: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.3.5.3.4 India: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.3.5.4 South Korea: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.4.1 South Korea: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.4.2 South Korea: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.3.5.4.3 South Korea: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.3.5.5 Australia: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.5.1 Australia: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.5.2 Australia: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.3.5.5.3 Australia: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.3.5.6 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.1 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.2 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)

9.3.5.6.3 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)

9.4 Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028

9.4.1 Overview

9.4.2 Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.3 Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)

9.4.5 Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)

9.4.5.1 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.1.1 Overview

9.4.5.1.2 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.1.3 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

9.4.5.1.4 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028, By Application (US$ Million)

9.4.5.2 South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.2.1 Overview

9.4.5.2.2 South Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.2.3 South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

9.4.5.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Application (US$ Million)

9.4.5.3 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.3.1 Overview

9.4.5.3.2 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.3.3 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

9.4.5.3.4 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028, By Application (US$ Million)

9.4.5.4 Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.4.1 Overview

9.4.5.4.2 Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9.4.5.4.3 Rest of Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Application (US$ Million)

9.5 South And Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts To 2028

9.5.1 Overview

9.5.2 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

9.5.3 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)

9.5.4 South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.5.5 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Country (%)

9.5.5.1 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

9.5.5.1.1 Overview

9.5.5.1.2 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

9.5.5.1.3 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)

9.5.5.1.4 Brazil: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.5.5.2 Argentina: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028 (US$ Million)

9.5.5.2.1 Overview

9.5.5.2.2 Argentina Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

9.5.5.2.3 Argentina: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)

9.5.5.2.4 Argentina: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.5.5.3 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (USD Mn)

9.5.5.3.1 Overview

9.5.5.3.2 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (USD Mn)

9.5.5.3.3 Rest of South & Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028, By Tests (US$ Million)

9.5.5.3.4 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10. Impact Of COVID-19 Pandemic on Monoclonal Antibody Diagnostic Reagent Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Monoclonal Antibody Diagnostic Reagent Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Monoclonal Antibody Diagnostic Reagent Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 BioGenex

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Bio-Rad Laboratories, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Biocare Medical, LLC

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Celltrion Healthcare Co.,Ltd.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Creative Diagnostics

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 GenWay Biotech

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Thermo Fisher Scientific Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 ABclonal, Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Apto-Gen

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Abcam plc

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market

LIST OF TABLES.

Table 1. North America Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3. US Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 5. Canada Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 6. Canada Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 7. Mexico Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 9. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

Table 10. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11. UK: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

Table 12. UK: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 13. Germany: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

Table 14. Germany: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 15. France: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

Table 16. France: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 19. Spain: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

Table 20. Spain: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 21. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 23. Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 24. Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 25. China Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 26. China Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 27. Japan Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 28. Japan Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 29. India Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 30. India Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 31. South Korea Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 32. South Korea Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 33. Australia Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 34. Australia Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 35. Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)

Table 36. Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 37. Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

Table 38. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 39. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

Table 40. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 41. South Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

Table 42. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 43. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

Table 44. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 45. Rest of Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)

Table 46. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 47. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)

Table 48. South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 49. Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)

Table 50. Brazil: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 51. Argentina: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)

Table 52. Argentina: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of South & Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028, By Tests (US$ Million)

Table 54. Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 55. Organic Developments in the Monoclonal Antibody Diagnostic Reagent Market

Table 56. Inorganic Developments in the Monoclonal Antibody Diagnostic Reagent Market

Table 57. Glossary of Terms

LIST OF FIGURES.

Figure 1. Monoclonal Antibody Diagnostic Reagent Market Segmentation

Figure 2. Monoclonal Antibody Diagnostic Reagent Market, By Region

Figure 3. Global Monoclonal Antibody Diagnostic Reagent Market Overview

Figure 4. Enzyme Linked Immunosorbent Segment Held Largest Share of Tests Segment in Monoclonal Antibody Diagnostic Reagent Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Monoclonal Antibody Diagnostic Reagent Market, by Geography (US$ Million)

Figure 7. Global Monoclonal Antibody Diagnostic Reagent Market - Leading Country Markets (US$ Million)

Figure 8. Global Monoclonal Antibody Diagnostic Reagent Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East & Africa: PEST Analysis

Figure 13. South & Central America: PEST Analysis

Figure 14. Impact Analysis of Drivers and Restraints Pertaining to Monoclonal Antibody Diagnostic Reagent Market

Figure 15. Global Monoclonal Antibody Diagnostic Reagent Market – Revenue Forecast and Analysis – 2020- 2028

Figure 16. Global Monoclonal Antibody Diagnostic Reagent Market – By Geography Forecast and Analysis – 2022- 2028

Figure 17. Global Monoclonal Antibody Diagnostic Reagent Market – Market Potential Analysis, By Region

Figure 18. Market Positioning of Key Players in Global Monoclonal Antibody Diagnostic Reagent Market

Figure 19. Global Monoclonal Antibody Diagnostic Reagent Market – Comparative Company Analysis

Figure 20. Global Monoclonal Antibody Diagnostic Reagent Market – Growth Strategy Analysis

Figure 21. Global Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2021 & 2028 (%)

Figure 22. Double Antigen Sandwich Chemiluminescence Method: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Enzyme Linked Immunosorbent Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Recombinant Immunoblot Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Dot-immunogold Filtration Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Global Monoclonal Antibody Diagnostic Reagent Market Share by Application Segment - 2021 & 2028 (%)

Figure 27. Hormones Diagnosis: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28. Tumor Monitoring: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29. Virus Detection: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30. Other Applications: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. North America: Monoclonal Antibody Diagnostic Reagent Market, by Key Country – Revenue (2021) (US$ Million)

Figure 32. North America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 33. North America: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)

Figure 34. US: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Canada: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Mexico: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Key Country – Revenue (2021) (US$ Million)

Figure 38. Europe: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 39. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)

Figure 40. UK: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Germany: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. France: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Italy: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Spain: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Key Country – Revenue (2021) (US$ Million)

Figure 47. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 48. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)

Figure 49. China: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. Japan: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. India: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. South Korea: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. Australia: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)

Figure 55. Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 56. Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 57. Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)

Figure 58. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 59. South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 60. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 61. Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

Figure 62. South and Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue Overview, by Country, 2022 (US$ Million)

Figure 63. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

Figure 64. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Country (%)

Figure 65. Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

Figure 66. Argentina Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

Figure 67. Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (USD Mn)

Figure 68. Impact of COVID-19 Pandemic in North American Countries Markets

Figure 69. Impact of COVID-19 Pandemic in European Country Markets

Figure 70. Impact of COVID-19 Pandemic in Asia-Pacific Countries Markets

Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 72. Impact of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 73. Growth Strategies in the Monoclonal Antibody Diagnostic Reagent Market (%)

The List of Companies - Monoclonal Antibody Diagnostic Reagent Market

1. BioGenex

2. Bio-Rad Laboratories, Inc.

3. Biocare Medical, LLC

4. Celltrion Healthcare Co., Ltd.

5. Creative Diagnostics

6. GenWay Biotech

7. Thermo Fisher Scientific Inc.

8. ABclonal, Inc.

9. Apto-Gen

10. Abcam plc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the monoclonal antibody diagnostic reagent market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global monoclonal antibody diagnostic reagent market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TOP